Prevalence, morphologic characteristic and predictors of organization of atrial auricle thrombi four weeks after anticoagulant preparation to scheduled electrical cardioversion of atrial fibrillation.
DOI:
https://doi.org/10.26641/2307-0404.2013.3.18945Keywords:
atrial fibrillation, atrial auricle thrombosis, thromboembolism complications, transesophageal echocardiographyAbstract
Goal: to study thrombosis prevalence and predictors of thrombi organization in atrial auricles in persistent non-valvular atrial fibrillation (NVAF) in patients undergoing transesophageal echocardiography (TEE) 4 weeks after oral anticoagulant therapy (OAC). Materials and methods: a total of 133 consecutive patients with NVAF, who underwent TЕE before electrical cardioversion (ECV) were included in the study. Results: The mean age of the participants was 60,3±0,9 years, 95 (71,4%) were men. The mean term of the last AF episode was 6,5±0,6 months. Duration of AF less than 1 year was in 47 (35,3%) patients, from 1 to 5 years – in у 61 (45,8%) patients, over 5 years – in 25 (18,8%) patients. 14 (10,5%) patients had underlying coronary artery disease (CAD), 84 (63,2%) patients had arterial hypertension, 31 (23,3%) had both CAD and arterial hypertension, 4 (3,0%) had cardiomyopathy, 80 (60,2%) were obese. NYHA I FC of heart failure (HF) was diagnozed in 8 (6,0%) patients, II FC – in 94 (70,7%) patients and III FC – in 31 (23,3%) patients. GFR > 90 ml/min/1,73m² was in 9 (6,8%) patients, in 74 (55,6%) it was decreased to 60-89 ml/min/1,73m², in 50 (37,6%) patients GFR was 30-59 ml/min/1,73m². In stratification of risk of thromboembolism complications (TEC) 91 (68,4%) fell into the high-risk group with the CHA2DS2-VASc score ≥ 2, 32 (24,1%) patients were in the moderate-risk group and 10 (7,5%) had CHA2DS2-VASc score 0. TEE was performed in all patients 4 weeks after effective OAC therapy. In 40 (37,6%) patients thrombi were detected in the left atrial auricle and in 26 (65,0%) patients they were organized. In 10 (7,5%) patients thrombis were detected in right atrial auricles and in 7 (70,0%) patients they were organized. In 63 (47,4%) patients thrombi were found in both atrial auricles and in 25 (39,7%) patients they were organized. Correlation was found between detection of non-organized thrombi, duration of AF less than 1 year and increase of total cholesterol. Thrombus organization was assotiated with AF duration more than 1 year. Conclusions: Clinical predictors linked with detection of non-organized atrial auricles thrombi in NVAF patients 4 weeks after OAC therapy are duration of AF less than 1 year, increase of total cholesterol, while thrombi organization is assotiated with AF duration more than 1 year.References
Маркеры риска тромбоэмболических ослож¬нений у пациентов с персистирующей фибрилляцией предсердий / М.Р. Икоркин, О.И. Жаринов, Н.П. Лев¬чук [и др.] // Укр. кардиол. журнал. – 2009. – № 6. – C. 32-40.
Оценка признаков тромбообразования у боль¬ных с длительным пароксизмом фибрилляции пред¬сердий методом чреспищеводной эхокардиографии / О.С. Сычев, А.О. Бородай, Е.Н. Романова [и др.] // Укр. кардиол. журнал. – 2010. – № 2. – С. 54-60.
Феномен спонтанного эхоконтрастирования в полости левого предсердия при постоянной форме мерцательной аритмии: что влияет на его выра¬жен¬ность? / А.Н. Сумин, Д.Н. Кинев, В.В. Агаджанян [и др.] // Кардиология. – 1999. – № 2. – С. 60-65.
Чреспищеводная эхокардиография в диагнос¬тике объемных образований сердца и паракардиаль¬ного пространства / И.Е. Рыкунов, В.А. Сандриков, Т.Д. Буравихина [и др.] // Кардиология. – 1996. – № 12. – С. 95-101.
Чреспищеводная эхокардиография в оценке состояния ушка левого предсердия у больных с па¬роксизмальной формой фибрилляции предсердий / М. Н. Алехин, С.Б. Ваниев, Е.Н. Майба [и др.] // Крем¬левская медицина. Клинич. вестник. – 2003. - № 3. – С. 15-17.
Advanced age, low left atrial appendage velocity, and factor V promoter sequence variation as predictors of left atrial thrombosis in patients with non-valvular atrial fibrillation / D.A. Zateyshchikov, A.N. Brovkin, D.A. Chis¬tia¬kov [et al.] // J. Thromb. Thrombolysis. – 2010. – Vol. 30, N 2. – P. 192-199.
Antithrombotic therapy in atrial fibrillation / G.W. Albers, J.E. Dalen, A. Laupacis [et al.] // Chest. – 2001. – Vol. 119, N 1. – P. 194-206.
Fatkin D. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic con¬trast and thromboembolic risk in vivo / D. Fatkin, R.P. Kel¬ly, M.P. Feneley // J. Am. Coll. Cardiol. – 1994. – Vol. 23. – P. 961-969.
Focused update of the ESC Guidelines for the management of atrial fibrillation / Eur. Heart. J. – 2012. – Vol. 33. – P. 2719-2747.
Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation / D. Scherr, D. Dalal, K. Chilukuri [et al.] // J. Cardiovasc. Electro¬phy¬siol. – 2009. – Vol. 20. – P. 379-384.
The use of anatomic M-mode echocardiography to determine the left atrial appendage functions in patients with sinus rhythm / A. Mahilmaran, P. G. Nayar, G. Su¬dar¬sana [et al.] // Echocardiography. – 2005. – Vol. 22, N 2. – P. 99-103.
Ikorkin MR, Zharinov OI, Levchuk NP. Markery riska tromboembolicheskikh oslozhneniy u patsientov s persistiruyushchey fibrillyatsiey predserdiy. Ukr. kardiol. zhurnal. 2009;6:32-40.
Sychev OS, Boroday AO, Romanova EN. Otsen¬ka priznakov tromboobrazovaniya u bol'nykh s dlitel'nym paroksizmom fibrillyatsii predserdiy metodom chres¬pishche¬vodnoy ekhokardiografii. Ukr. kardiol. zhurnal. 2010;2:54-60.
Sumin AN, Kinev DN, Agadzhanyan VV. Fe¬nomen spontannogo ekhokontrastirovaniya v polosti le¬vogo predserdiya pri postoyannoy forme mertsatel'noy aritmii: chto vliyaet na ego vyrazhennost'? Kardiologiya. 1999;2:60-65.
Rykunov IE, Sandrikov VA, Buravikhina TD. Chres¬pishchevodnaya ekhokardiografiya v diagnostike ob"emnykh obrazovaniy serdtsa i parakardial'nogo prost¬ranstva. Kardiologiya. 1996;12:95-101.
Alekhin MN, Vaniev SB, Mayba EN. Chres¬pishche¬vodnaya echocardiografiya v otsenke sostoyaniya ushka levogo predserdiya u bol'nykh s paroksizmal'noy formoy fibrillyatsii predserdiy. Kremlevskaya meditsina. Klinicheskiy vestnik. 2003;3:15-17.
Zateyshchikov DA, Brovkin AN, Chistiakov DA. Advanced age, low left atrial appendage velocity, and factor V promoter sequence variation as predictors of left atrial thrombosis in patients with non-valvular atrial fibrillation. J. Thromb. Thrombolysis. 2010;30(2):192-9.
Albers GW, Dalen JE, Laupacis A. Antithrom¬botic therapy in atrial fibrillation. Chest. 2001;119(1):194-206.
Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spon¬taneous echocardiographic contrast and thromboembolic risk in vivo. J. Am. Coll. Cardiol. 1994;23:961-9.
Focused update of the ESC Guidelines for the ma¬nagement of atrial fibrillation. Eur. Heart. J. 2012;33:2719-47.
Scherr D, Dalal D, Chilukuri K. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 2009;20:379-84.
Mahilmaran A, Nayar PG, Sudarsana G. The use of anatomic M-mode echocardiography to determine the left atrial appendage functions in patients with sinus rhythm. Echocardiography. 2005;22(2):99-103.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Medical Perspectives
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
